<DOC>
	<DOCNO>NCT03070314</DOCNO>
	<brief_summary>In bioavailability trial show one main active constituent alcoholic echinacea extract , alkylamide dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide ( short : tetraen ) bioavailable child different age group intake 5 Echinaforce junior tablet .</brief_summary>
	<brief_title>Echinaforce Junior Bioavailability Trial</brief_title>
	<detailed_description>In bioavailability trial show one main active constituent alcoholic echinacea extract , alkylamide dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide ( short : tetraen ) bioavailable child different age group intake 5 Echinaforce junior tablet . Six capillary blood draw take follow time point : Start ( 0 ) , 15 , 30 , 60 , 90 , 270 minute thereafter bioavailability measure calculate .</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<criteria>Children age group 412 year uncomplicated common cold ( upper respiratory tract infection ) First symptom appear within last 72 hour Written consent give parent verbal consent child capable judgement Not able fast 2 hour prior treatment intake another preparation contain echinacea within last 24 hour Participation clinical trial within last 30 day progressive systemic illness , include tuberculosis , leukemia , connective tissue disease , multiple sclerosis , autoimmune disease ; history relevant allergy , include allergy Compositae plant</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Echinacea</keyword>
	<keyword>bioavailability</keyword>
	<keyword>child</keyword>
</DOC>